20182020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Elisabetta Sara Montagna is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • The presence of concomitant mutations affects the activity of egfr tyrosine kinase inhibitors in egfr-mutant non-small cell lung cancer (Nsclc) patients

    Rachiglio, A. M., Fenizia, F., Piccirillo, M. C., Galetta, D., Crinò, L., Vincenzi, B., Barletta, E., Pinto, C., Ferraù, F., Lambiase, M., Montanino, A., Roma, C., Ludovini, V., Montagna, E. S., Luca, A. D., Rocco, G., Botti, G., Perrone, F., Morabito, A. & Normanno, N., Mar 10 2019, In : Cancers. 11, 3, 341.

    Research output: Contribution to journalArticle

    Open Access
  • Chemotherapy-induced nausea and vomiting (CINV) in patients with advanced lung cancer during the first-line treatment: assessment by physicians, nurses, and patients from an Italian multicenter survey

    Carnio, S., Galetta, D., Scotti, V., Cortinovis, D. L., Antonuzzo, A., Pisconti, S., Rossi, A., Martelli, O., Cecere, F. L., Lunghi, A., Del Conte, A., Montagna, E. S., Topulli, J., Pelizzoni, D., Rapetti, S. G., Gianetta, M., Pacchiana, M. V., Pegoraro, V., Cataldo, N., Bria, E. & 1 others, Novello, S., Jun 1 2018, In : Supportive Care in Cancer. 26, 6, p. 1841-1849 9 p.

    Research output: Contribution to journalArticle